Evidence map›Paper›PMID 18996844›Full record

ArticleThe Journal of biological chemistry2009

Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway.

Masaaki Nakayama, Junzo Hisatsune, Eiki Yamasaki, Hajime Isomoto, Hisao Kurazono, Masanori Hatakeyama, Takeshi Azuma, Yoshio Yamaoka, Kinnosuke Yahiro, Joel Moss and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 142 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Frontiers in microbiology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Reactive Oxygen Species andAntioxidants (Basel, Switzerland) · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. Helicobacter pyloriBioengineered · 2022
    Article
  16. Review
  17. DNMT1 Gene Expression in Patients withTheScientificWorldJournal · 2022
    Article
  18. Article
  19. Review
  20. Bacteria-Cancer Interface: Awaiting the Perfect Storm.Pathogens (Basel, Switzerland) · 2021
    Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Masaaki NakayamaDepartment of Bacteriology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 8528523, Japan.
Junzo Hisatsune
Eiki Yamasaki
Hajime Isomoto
Hisao Kurazono
Masanori Hatakeyama
Takeshi Azuma
Yoshio Yamaoka
Kinnosuke Yahiro
Joel Moss
Toshiya Hirayama
Nagasaki University · JPNational Institutes of Health · USObihiro University of Agriculture and Veterinary Medicine · JPBaylor College of Medicine · USHokkaido University · JPKobe University · JP

Funding

ADP-ribosylation CyclesZIAHL000659 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MOSS, JOEL · 2009 to 2025
$29.8M
Intramural NIH HHS
6 · The paper itself

Abstract

Helicobacter pylori VacA toxin contributes to the pathogenesis and severity of gastric injury. We found that incubation of AZ-521 cells with VacA resulted in phosphorylation of protein kinase B (Akt) and glycogen synthase kinase-3beta (GSK3beta) through a PI3K-dependent pathway. Following phosphorylation and inhibition of GSK3beta,beta-catenin was released from a GSK3beta/beta-catenin complex, with subsequent nuclear translocation. Methyl-beta-cyclodextrin (MCD) and phosphatidylinositol-specific phospholipase C (PI-PLC), but not 5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB) and bafilomycin A1, inhibited VacA-induced phosphorylation of Akt, indicating that it does not require VacA internalization and is independent of vacuolation. VacA treatment of AZ-521 cells transfected with TOPtkLuciferase reporter plasmid or control FOPtkLucifease reporter plasmid resulted in activation of TOPtkLuciferase, but not FOPtkLucifease. In addition, VacA transactivated the beta-catenin-dependent cyclin D1 promoter in a luciferase reporter assay. Infection of AZ-521 cells by a vacA mutant strain of H. pylori failed to induce phosphorylation of Akt and GSK3beta, or release of beta-catenin from a GSK3beta/beta-catenin complex. Taken together, these results support the conclusion that VacA activates the PI3K/Akt signaling pathway, resulting in phosphorylation and inhibition of GSK3beta, and subsequent translocation ofbeta-catenin to the nucleus, consistent with effects of VacA on beta-catenin-regulated transcriptional activity. These data introduce the possibility that Wnt-dependent signaling might play a role in the pathogenesis of H. pylori infection, including the development of gastric cancer.

Indexed as

Helicobacter pyloriActive Transport, Cell NucleusBacterial Proteinsbeta CateninCell Line, TumorCell NucleusCyclin D1Enzyme InhibitorsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHelicobacter InfectionsHumansMutationPhosphatidylinositol 3-KinasesPhospholipase C betaPhosphorylationBacterial Proteinsbeta CateninCCND1 protein, humanCyclin D1Enzyme InhibitorsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGSK3B protein, humanPhosphatidylinositol 3-KinasesPhospholipase C betaProto-Oncogene Proteins c-aktVacA protein, Helicobacter pyloriWnt Proteins

Identifiers

PMID18996844
PMCPMC2615499
OpenAlexW1981502091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.